Evidence map›Paper›PMID 40603582›Full record

ArticleNature cardiovascular research2025

Multimodal AI to forecast arrhythmic death in hypertrophic cardiomyopathy.

Changxin Lai, Minglang Yin, Eugene G Kholmovski, Dan M Popescu, Dai-Yin Lu, Erica Scherer, Edem Binka, Stefan L Zimmerman, Jonathan Chrispin, Allison G Hays and 3 more

Abstract read
In one paragraph

Article in Nature cardiovascular research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Changxin LaiAlliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-3585-5979
Minglang YinAlliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-7861-350X
Eugene G KholmovskiAlliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-3271-7247
Dan M PopescuAlliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.
Dai-Yin LuHypertrophic Cardiomyopathy Center of Excellence, Division of Cardiology, University of California, San Francisco, San Francisco, CA, USA.
Erica SchererSanger Heart & Vascular Institute, Atrium Health, Charlotte, NC, USA.ORCID http://orcid.org/0009-0003-7458-4328
Edem BinkaDivision of Pediatric Cardiology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
Stefan L ZimmermanSchool of Medicine, Johns Hopkins University, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-9422-6742
Jonathan ChrispinSchool of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Allison G HaysSchool of Medicine, Johns Hopkins University, Baltimore, MD, USA.ORCID http://orcid.org/0000-0003-2138-1589
Dermot M PhelanSanger Heart & Vascular Institute, Atrium Health, Charlotte, NC, USA.
M Roselle AbrahamHypertrophic Cardiomyopathy Center of Excellence, Division of Cardiology, University of California, San Francisco, San Francisco, CA, USA.
Natalia A TrayanovaAlliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA. ntrayanova@jhu.edu.ORCID http://orcid.org/0000-0002-8661-063X

Funding

Artificial intelligence analysis of atrial remodeling evolution in patients with atrial fibrillation: Towards optimal ablation strategiesR01HL166759 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Eugene Kholmovski, David Spragg · 2023 to 2026
$3.2M
Heart Digital Twin Analysis of Arrhythmias due to Infiltrating AdiposityR01HL174440 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI NATALIA A. TRAYANOVA · 2024 to 2026
$2.1M
NHLBI NIH HHS R01 HL166759NHLBI NIH HHS R01 HL174440U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL166759U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL174440U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R35HL1431598
6 · The paper itself

Abstract

Sudden cardiac death from ventricular arrhythmias is a leading cause of mortality worldwide. Arrhythmic death prognostication is challenging in patients with hypertrophic cardiomyopathy (HCM), a setting where current clinical guidelines show low performance and inconsistent accuracy. Here, we present a deep learning approach, MAARS (Multimodal Artificial intelligence for ventricular Arrhythmia Risk Stratification), to forecast lethal arrhythmia events in patients with HCM by analyzing multimodal medical data. MAARS' transformer-based neural networks learn from electronic health records, echocardiogram and radiology reports, and contrast-enhanced cardiac magnetic resonance images, the latter being a unique feature of this model. MAARS achieves an area under the curve of 0.89 (95% confidence interval (CI) 0.79-0.94) and 0.81 (95% CI 0.69-0.93) in internal and external cohorts and outperforms current clinical guidelines by 0.27-0.35 (internal) and 0.22-0.30 (external). In contrast to clinical guidelines, it demonstrates fairness across demographic subgroups. We interpret MAARS' predictions on multiple levels to promote artificial intelligence transparency and derive risk factors warranting further investigation.

Indexed as

Arrhythmias, CardiacCardiomyopathy, HypertrophicDeath, Sudden, CardiacDecision Support TechniquesDeep LearningMultimodal ImagingAdultAgedEchocardiographyElectronic Health RecordsFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPredictive Value of Tests

Identifiers

PMID40603582
PMCPMC12259465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.